Developing new advanced molecular diagnostic solutions to help patients make better decisionsMBD
-
About Atturos
A new and fast growing clinical diagnostics company developing molecular diagnostic tests to support better patient decisions
-
Our Team
A highly experienced team focussed on patient-orientated development and delivery of innovative new molecular diagnostic tests to market
-
OCProDx
A non-invasive multiplexed protein blood test that reports a key property of prostate cancer by providing a tumour confinement score
-
Our Vision
To become a leading provider of clinical information by delivering diagnostic tools to fulfil significant unmet patient and healthcare provider needs